We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$296M
AUM Growth
-$72M
Cap. Flow
-$84.2M
Cap. Flow %
-28.48%
Top 10 Hldgs %
6.88%
Holding
509
New
39
Increased
197
Reduced
202
Closed
70

Top Buys

Rank Stock Value
1
CEG icon
Constellation Energy
CEG
+$1.64M
2
VEEV icon
Veeva Systems
VEEV
+$1.51M
3
CSCO icon
Cisco
CSCO
+$1.5M
4
FOXA icon
Fox Class A
FOXA
+$1.48M
5
DASH icon
DoorDash
DASH
+$1.48M

Top Sells

Rank Stock Value
1
VABS icon
Virtus Newfleet ABS/MBS ETF
VABS
+$32.2M
2
VSHY icon
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
+$24.6M
3
SEIX icon
Virtus SEIX Senior Loan ETF
SEIX
+$19M
4
SMC
Summit Midstream
SMC
+$3.67M
5
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$2.09M

Sector Composition

Rank Sector Weight
1 Financials 33.24%
2 Healthcare 17.43%
3 Technology 12.41%
4 Industrials 9.1%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLAD icon
176
Gladstone Capital
GLAD
$446M
$597K 0.2%
22,133
-3,137
-12% -$81.3K
MPV
177
Barings Participation Investors
MPV
$176M
$572K 0.19%
28,448
-10,501
-27% -$185K
BCIC
178
BCP Investment Corp
BCIC
$92.9M
$546K 0.18%
43,619
+5,775
+15% +$70.6K
CRSP icon
179
CRISPR Therapeutics
CRSP
$5.17B
$524K 0.18%
10,765
+2,860
+36% +$111K
MRCC
180
DELISTED
Monroe Capital Corp
MRCC
$523K 0.18%
82,292
+6,693
+9% +$44.8K
OFS icon
181
OFS Capital
OFS
$51.9M
$523K 0.18%
61,914
-16,664
-21% -$143K
MAIN icon
182
Main Street Capital
MAIN
$5.48B
$518K 0.18%
8,758
-624
-7% -$34.5K
WHF icon
183
WhiteHorse Finance
WHF
$146M
$508K 0.17%
58,256
-74,765
-56% -$688K
IONS icon
184
Ionis Pharmaceuticals
IONS
$9.4B
$493K 0.17%
12,476
+2,775
+29% +$90.8K
OXSQ icon
185
Oxford Square Capital
OXSQ
$157M
$492K 0.17%
220,488
-11,097
-5% -$26.6K
BBIO icon
186
BridgeBio Pharma
BBIO
$16.5B
$484K 0.16%
11,208
-1,770
-14% -$64.4K
ALNY icon
187
Alnylam Pharmaceuticals
ALNY
$29.3B
$476K 0.16%
1,459
-8
-0.5% -$2.21K
EXEL icon
188
Exelixis
EXEL
$13.4B
$469K 0.16%
10,637
+428
+4% +$17.1K
ARDX icon
189
Ardelyx
ARDX
$997M
$468K 0.16%
119,461
+50,946
+74% +$210K
TBPH icon
190
Theravance Biopharma
TBPH
$877M
$462K 0.16%
41,884
+5,505
+15% +$53.5K
INSM icon
191
Insmed
INSM
$28.6B
$462K 0.16%
4,587
-399
-8% -$30.5K
MIRM icon
192
Mirum Pharmaceuticals
MIRM
$6.14B
$461K 0.16%
9,066
+574
+7% +$25.6K
AUPH icon
193
Aurinia Pharmaceuticals
AUPH
$2.11B
$457K 0.15%
53,997
+16,946
+46% +$136K
MDGL icon
194
Madrigal Pharmaceuticals
MDGL
$11.8B
$452K 0.15%
1,495
+307
+26% +$91.5K
BNTX icon
195
BioNTech
BNTX
$23.5B
$451K 0.15%
4,236
+1,260
+42% +$127K
ASND icon
196
Ascendis Pharma A/S
ASND
$16.8B
$449K 0.15%
2,600
-147
-5% -$23.9K
MRNA icon
197
Moderna
MRNA
$23.6B
$448K 0.15%
16,248
+7,863
+94% +$207K
REGN icon
198
Regeneron Pharmaceuticals
REGN
$80.8B
$447K 0.15%
852
+366
+75% +$204K
NBIX icon
199
Neurocrine Biosciences
NBIX
$16.6B
$447K 0.15%
3,555
+722
+25% +$82.8K
UTHR icon
200
United Therapeutics
UTHR
$23.1B
$446K 0.15%
1,553
+559
+56% +$167K
6 7
8
9 10

Similar funds

RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

Virtus Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Virtus Investment Advisers held 509 positions worth $296M, down 20% from $368M the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

Virtus Investment Advisers withdrew a net $84.2M in Q2 2025, closing 70 positions and reducing 202 holdings. Its most notable exit was Virtus Newfleet ABS/MBS ETF, an estimated $32.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Virtus Investment Advisers opened a new position in Constellation Energy worth $2.01M.

  • Virtus Investment Advisers's largest Q2 2025 buy was Constellation Energy: 6,213 shares worth $2.01M.
  • Virtus Investment Advisers added most to Amgen in Q2 2025, an estimated $1.45M increase.
  • Virtus Investment Advisers's biggest Q2 2025 reduction was EOG Resources, cutting an estimated $1.23M.
  • Virtus Investment Advisers fully exited Virtus Newfleet ABS/MBS ETF in Q2 2025, selling an estimated $32.2M.
  • Virtus Investment Advisers's ten largest holdings make up 6.9% of its $296M portfolio in Q2 2025.
  • Virtus Investment Advisers opened 39 new positions and closed 70 in Q2 2025.
  • Virtus Investment Advisers's portfolio value fell 20% quarter-over-quarter to $296M.

Based on Virtus Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.